CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer. Mukohyama J, Agawa K, Yamashita K, Matsuda T, et al. Anticancer Res 2023;43:3763-3767.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mukohyama J, Agawa K, Yamashita K, Matsuda T, et al. CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer. Anticancer Res 2023;43:3763-3767.
PMID: 37500172